Citations

Showing 10 of 108104 citations.

Deep residual inception encoder‐decoder network for amyloid PET harmonization
Shah, Jay , Gao, Fei , Ghisays, Valentina , Luo, Ji , Chen, Yinghua , Lee, Wendy , Zhou, Yuxiang, Reiman, Eric M. , Li, Baoxin , Zhou, Yuxiang , Benzinger, Tammie L.S. , Chen, Kewei , Su, Yi , Wu, Teresa

Mayo Clinic

Alzheimer's & Dementia | February 10, 2022 | Volume: 18 | Issue: 12 | Pages: 2448-2457

10.1002/alz.12564 | PMID 35142053 Get It

AbstractIntroductionMultiple positron emission tomography (PET) tracers are available for amyloid imaging, posing a significant challenge to consensus interpretation and quantitative analysis. We accordingly developed and validated a deep learning model as a harmonization strategy.MethodA Residual Inception Encoder‐Decoder Neural Network was developed to harmonize images between amyloid PET image pairs made with Pittsburgh Compound‐B and florbetapir tracers. The model was trained using a dataset with 92 subjects with 10‐fold cross validation and its generalizability was further examined using an independent external dataset of 46 subjects.ResultsSignificantly stronger between‐tracer correlations (P < .001) were observed after harmonization for both global amyloid burden indices and voxel‐wise measurements in the training cohort and the external testing cohort.DiscussionWe proposed and validated a novel encoder‐decoder based deep model to harmonize amyloid PET imaging data from different tracers. Further investigation is ongoing to improve the model and apply to additional tracers.
A Label-Free Electrical Impedance Spectroscopy for Detection of Clusters of Extracellular Vesicles Based on Their Unique Dielectric Properties
Zhang, Yuqian , Murakami, Kazutoshi , Borra, Vishnupriya J., Ozen, Mehmet Ozgün , Demirci, Utkan , Nakamura, Takahisa , Esfandiari, Leyla

Mayo Clinic

Biosensors | February 9, 2022 | Volume: 12 | Issue: 2 | Pages: 104

10.3390/bios12020104 | PMID 35200364 Get It

Extracellular vesicles (EVs) have gained considerable attention as vital circulating biomarkers since their structure and composition resemble the originating cells. The investigation of EVs’ biochemical and biophysical properties is of great importance to map them to their parental cells and to better understand their functionalities. In this study, a novel frequency-dependent impedance measurement system has been developed to characterize EVs based on their unique dielectric properties. The system is composed of an insulator-based dielectrophoretic (iDEP) device to entrap and immobilize a cluster of vesicles followed by utilizing electrical impedance spectroscopy (EIS) to measure their impedance at a wide frequency spectrum, aiming to analyze both their membrane and cytosolic charge-dependent contents. The EIS was initially utilized to detect nano-size vesicles with different biochemical compositions, including liposomes synthesized with different lipid compositions, as well as EVs and lipoproteins with similar biophysical properties but dissimilar biochemical properties. Moreover, EVs derived from the same parental cells but treated with different culture conditions were characterized to investigate the correlation of impedance changes with biochemical properties and functionality in terms of pro-inflammatory responses. The system also showed the ability to discriminate between EVs derived from different cellular origins as well as among size-sorted EVs harbored from the same cellular origin. This proof-of-concept approach is the first step towards utilizing EIS as a label-free, non-invasive, and rapid sensor for detection and characterization of pathogenic EVs and other nanovesicles in the future.
Duration Of Delayed Graft Function And Its Impact On Graft Outcomes In Deceased Donor Kidney Transplantation Running Head: Impact of Duration of Delayed Graft Function
Reddy, Kunam S. , Butterfield, Richard , Moss, Adyr A. , Khamash, Hassan A., Kodali, Lavanya , Misra, Suman , Heilman, Raymond L. , Budhiraja, Pooja , Jadlowiec, Caroline C.

Mayo Clinic

No container title available | February 9, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1277907/v1 Get It

Abstract Background. There is controversy regarding the impact of delayed graft function (DGF) on kidney transplant outcomes. We hypothesize that the duration of DGF, rather than DGF itself, is associated with long-term kidney graft function.Methods. We analyzed all deceased donor kidney transplants (DDKT) done at our center between 2008 to 2020 with DGF to determine factors associated with DGF duration as well as the impact of DGF duration on 1) acute rejection, BKV infection, progression of fibrosis on protocol biopsy, and death censored graft survival 2) resource utilization, including hospital length of stay and readmissions. DGF duration was assessed at three 14-day intervals: <14 DGF days, 14-27 DGF days, >28 DGF days.Results. There were 1714 DDKT were included, 59.4% (n=1018) had DGF. The median DGF duration was 10 days IQR (6,15). The majority of recipients (95%) had resolution of DGF within 28 days. Donor factors associated with DGF days were longer cold ischemia time, donor on inotropes, older age, donation after circulatory death, higher terminal creatinine, and hypertension. Recipient factors associated with increased DGF duration included male sex, length on dialysis before transplant, and higher body mass index. There were no differences in acute rejection events or interstitial fibrosis progression by 4 months when comparing DGF days. The median length of stay was 3 days. However, readmissions increased with increasing DGF duration. Death-censored graft survival was not associated with the length of DGF except when DGF lasted >28 days. Conclusions. Inferior graft survival was observed only in recipients of DDKT with DGF lasting beyond 28 days. DGF lasting <28 days had no impact on graft survival. Duration of DGF, rather than DGF itself, is associated with graft survival. Trial Registration. Retrospective study approved by Mayo Clinic IRB.
The Anatomy behind Eyebrow Positioning: A Clinical Guide Based on Current Anatomic Concepts
Cotofana, Sebastian, Solish, Nowell, Gallagher, Conor, Beleznay, Katie, Hernandez, Claudia A., Bertucci, Vince, Cotofana, Sebastian, Solish, Nowell, Gallagher, Conor, Beleznay, Katie, Hernandez, Claudia A., Bertucci, Vince

Mayo Clinic

Plastic & Reconstructive Surgery | February 9, 2022 | Volume: 149 | Issue: 4 | Pages: 869-879

10.1097/prs.0000000000008966 | PMID 35139063 Get It

Background: The position of the eyebrow is known to reflect emotional status and to provide a plethora of nonverbal information. Although the eyebrow has no direct attachment to underlying bone, it is subject to the interplay between the various periorbital muscles, which when acting together, permit important nonverbal cues to be conveyed. Understanding the balance and interplay between these muscles is of crucial importance when targeting the periorbital area with neuromodulators. The authors’ aims were to summarize current anatomic and clinical knowledge so as to provide a foundation that physicians can rely on to improve and increase the predictability of patient outcomes when treating the periorbital region with neuromodulators for aesthetic purposes. Methods: This narrative review is based on the anatomic and clinical experience of the authors dissecting and treating the periorbital region with specific focus on the glabella and the forehead. Results: This narrative review covers (1) a brief description of the relevant periorbital muscle anatomy, (2) an analysis of each muscle’s contribution to various facial expressions, and (3) an anatomic and physiologic simulation of the muscular effects of specific neuromodulator injection sites. Conclusion: By understanding functional anatomy of the periorbital muscles and combining this knowledge with individualized assessment and treatment planning, it is possible to achieve aesthetically pleasing, predictable, and reproducible treatment outcomes that positively impact perception of nonverbal cues when administering neuromodulators.
An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson’s Disease
Lea, RoShunna, Beach, Thomas G. , Belden, Christine M. , Shill, Holly A. , Driver‐Dunckley, Erika, Mehta, Shyamal H. , Driver-Dunckley, Erika, Benge, Jared F. , Adler, Charles H. , Zhang, Nan , Driver‐Dunckley, Erika , Atri, Alireza

Mayo Clinic

Journal of Clinical and Experimental Neuropsychology | February 9, 2022 | Volume: 43 | Issue: 9 | Pages: 918-925

10.1080/13803395.2022.2034753 | PMID 35138228 Get It

Targeted ablation of gastric pacemaker sites to modulate patterns of bioelectrical slow wave activation and propagation in an anesthetized pig model
Aghababaie, Zahra , Cheng, Leo K. , Paskaranandavadivel, Niranchan , Avci, Recep , Chan, Chih-Hsiang Alexander , Matthee, Ashton , Asirvatham, Samuel J. , Farrugia, Gianrico , O’Grady, Gregory , Angeli, Timothy R. , Farrugia, Gianrico , O'Grady, Gregory , Angeli-Gordon, Timothy R , Asirvatham, Samuel J , Paskaranandavadivel, Niranchan , Amirapu, Satya , Beyder, Arthur

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | February 9, 2022 | Volume: 322 | Issue: 4 | Pages: G431-G445

10.1152/ajpgi.00332.2021 | PMID 35137624 Get It

This study presents gastric ablation as a novel tool for modulating gastric bioelectrical activation, including eliminating the normal gastric pacemaker site as well as abnormal ectopic pacemaker sites underlying gastric dysrhythmias. Targeted application of radiofrequency ablation was able to eliminate these pacemaker sites without disrupting surrounding conduction capability or tissue structure. Gastric ablation presents a powerful new research tool for modulating gastric electrical activation and may likely hold therapeutic potential for disorders of gastric function.
Antibiotic Stewardship Strategies and Their Association With Antibiotic Overuse After Hospital Discharge: An Analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework
Vaughn, Valerie M. , Ratz, David, Greene, M. Todd , Flanders, Scott A. , Gandhi, Tejal , Petty, Lindsay A , Huls, Sean, Feng, Xiaomei , White, Andrea T. , Hersh, Adam L. , Vaughn, Valerie M

Mayo Clinic

Clinical Infectious Diseases | February 9, 2022 | Volume: 75 | Issue: 6 | Pages: 1063-1072

10.1093/cid/ciac104 | PMID 35143638 Get It

Abstract Background Strategies to optimize antibiotic prescribing at discharge are not well understood. Methods In fall 2019, we surveyed 39 Michigan hospitals on their antibiotic stewardship strategies. The association of reported strategies with discharge antibiotic overuse (unnecessary, excess, suboptimal fluoroquinolones) for community-acquired pneumonia (CAP) and urinary tract infection (UTI) was evaluated in 2 ways: (1) all strategies assumed equal weight and (2) strategies were weighted based on the ROAD (Reducing Overuse of Antibiotics at Discharge) Home Framework (ie, Tier 1—Critical infrastructure, Tier 2—Broad inpatient interventions, Tier 3—Discharge-specific strategies) with Tier 3 strategies receiving the highest weight. Results Between 1 July 2017 and 30 July 2019, 39 hospitals with 20 444 patients (56.5% CAP; 43.5% UTI) were included. Survey response was 100%. Hospitals reported a median (interquartile range [IQR]) 12 (9–14) of 34 possible stewardship strategies. On analyses of individual stewardship strategies, the Tier 3 intervention, review of antibiotics prior to discharge, was the only strategy consistently associated with lower antibiotic overuse at discharge (adjusted incident rate ratio [aIRR] 0.543, 95% confidence interval [CI]: .335–.878). On multivariable analysis, weighting by ROAD Home tier predicted antibiotic overuse at discharge for both CAP and UTI. For diseases combined, having more weighted strategies was associated with lower antibiotic overuse at discharge (aIRR 0.957, 95% CI: .927–.987, per weighted intervention); discharge-specific stewardship strategies were associated with a 12.4% relative decrease in antibiotic overuse days at discharge. Conclusions The more stewardship strategies a hospital reported, the lower its antibiotic overuse at discharge. However, Tier 3, or discharge-specific strategies, appeared to have the largest effect on antibiotic prescribing at discharge.
Scholarships Targeting Diversity and Inclusion: A Student’s Experience at Plastic Surgery the Meeting 2021
Antezana, Luis A., Banyard, Derek A., Butler, Paris D., Antezana, Luis A. , Antezana, Luis , Banyard, Derek A., Butler, Paris D.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | February 9, 2022 | Volume: 10 | Issue: 2 | Pages: e4091

10.1097/gox.0000000000004091 | PMID 35169523 Get It

Pseudoaneurysm of the Superficial Palmar Arch in a 6-month-old Child: A Case Report
Kwiecień, Grzegorz , Garbuzov, Anna , Boonipat, Thanapoom , Moran, Steven L. , Kwiecien, Grzegorz J, Houdek, Matthew T.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | February 9, 2022 | Volume: 10 | Issue: 2 | Pages: e4093

10.1097/gox.0000000000004093 | PMID 35169525 Get It

Summary: Hand aneurysms in infants are extremely rare and, unlike their adult counterparts, cannot be explained by repetitive trauma to the palm. When they occur, they are most often located in the ulnar artery. Usually there is no history of trauma, and an alternative diagnosis like malignancy must be excluded. Helpful physical findings to aid diagnosis include rapid appearance of a mass over the course of a few days, pulsatile nature, and location along the ulnar side of the hand. These cases can be challenging and excisional biopsy may be required if the lesion is thrombosed and does not have a characteristic appearance on imaging. Aneurysms located in the palmar arch or common digital arteries are usually treated with simple excision, while those located in the ulnar artery often require repair or reconstruction. Here we present a unique case of an infant with a pseudoaneurysm involving the superficial palmar arch on the radial side of the hand with a likely congenital etiology. Diagnostic challenges and treatment options are discussed.
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions
Zeidler, Julianna D. , Hogan, Kelly A. , Agorrody, Guillermo , Peclat, Thais , Kashyap, Sonu , Kanamori, Karina S. , Gomez, Lilian Sales , Mazdeh, Delaram Z., Warner, Gina M., Thompson, Katie L., Chini, Claudia C.S. , Chini, Eduardo N. , Peclat, Thais R , Chini, Eduardo Nunes

Mayo Clinic

American Journal of Physiology-Cell Physiology | February 9, 2022 | Volume: 322 | Issue: 3 | Pages: C521-C545

10.1152/ajpcell.00451.2021 | PMID 35138178 Get It

Nicotinamide adenine dinucleotide (NAD) acts as a cofactor in several oxidation-reduction (redox) reactions and is a substrate for a number of nonredox enzymes. NAD is fundamental to a variety of cellular processes including energy metabolism, cell signaling, and epigenetics. NAD homeostasis appears to be of paramount importance to health span and longevity, and its dysregulation is associated with multiple diseases. NAD metabolism is dynamic and maintained by synthesis and degradation. The enzyme CD38, one of the main NAD-consuming enzymes, is a key component of NAD homeostasis. The majority of CD38 is localized in the plasma membrane with its catalytic domain facing the extracellular environment, likely for the purpose of controlling systemic levels of NAD. Several cell types express CD38, but its expression predominates on endothelial cells and immune cells capable of infiltrating organs and tissues. Here we review potential roles of CD38 in health and disease and postulate ways in which CD38 dysregulation causes changes in NAD homeostasis and contributes to the pathophysiology of multiple conditions. Indeed, in animal models the development of infectious diseases, autoimmune disorders, fibrosis, metabolic diseases, and age-associated diseases including cancer, heart disease, and neurodegeneration are associated with altered CD38 enzymatic activity. Many of these conditions are modified in CD38-deficient mice or by blocking CD38 NADase activity. In diseases in which CD38 appears to play a role, CD38-dependent NAD decline is often a common denominator of pathophysiology. Thus, understanding dysregulation of NAD homeostasis by CD38 may open new avenues for the treatment of human diseases.